PharmacovigilanceOfficial

Slovenia's JAZMP publishes tenth Pharmacovigilance Bulletin, highlighting Amoksiklav suspension change

🇸🇮 JAZMP · Mon 26 Oct 2026

The Slovenian agency's latest bulletin for healthcare professionals covers a change in the formulation and preparation of Amoksiklav oral suspension and the mechanisms behind adverse drug reactions.

The Slovenian Agency for Medicinal Products and Medical Devices (JAZMP) has made the tenth issue of its Pharmacovigilance Bulletin available on its website, alongside the regular notices that the publication carries.

In the section headed "Izpostavljamo" ("We highlight"), the issue informs readers about a change in the formulation and preparation of Amoksiklav oral suspension. The source does not describe what has changed, so the practical details are not covered here and should be checked in the bulletin itself.

A second section, "Predstavljamo" ("We present"), discusses the mechanisms and circumstances in which adverse drug reactions occur.

JAZMP describes the bulletin as a free electronic publication aimed at healthcare professionals. It summarises new drug safety notices and important changes to medicine information, and appears up to four times a year. Readers can subscribe to receive it directly by email. The agency reference for the item is 1382-20/2026.

What it means for your team

  • Pharmacovigilance and quality teams with Amoksiklav oral suspension in their portfolio or responsibility should read the full bulletin to understand the formulation and preparation change, as the announcement gives no detail.
  • Changes to preparation instructions can matter for medication-error monitoring and product-information alignment, so teams may wish to check whether local materials need review.
  • The bulletin, published up to four times a year, collects safety notices and product-information changes relevant to Slovenia; subscribing offers a simple way to track them.

Official source: JAZMP ↗

Article written by VigiEye from the official source (JAZMP). AI-assisted; check the source before acting.

More Pharmacovigilance All →